Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats
-
U.S. regulators are trying to shut down the industry for compounded
weight-loss drugs, which could result in higher costs or suspend treatment
for patients.
1 ora fa
Nessun commento:
Posta un commento